SOLIGENIX, INC. 4
4 · SOLIGENIX, INC. · Filed Sep 27, 2013
Insider Transaction Report
Form 4
SOLIGENIX, INC.SNGX
HORGAN KEVIN
Senior VP; Chief Med Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-09-25+85,000→ 85,000 totalExercise: $0.68From: 2013-09-25Exp: 2022-12-04→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Issuer granted the stock option on December 5, 2012 (the "Grant Date"), subject to stockholder approval of an amendment to increase in the number of shares available for issuance the Company's 2005 Equity Incentive Plan (the "2005 Plan") under which the stock option was granted. The Issuer's stockholders approved the amendment to the 2005 Plan on September 25, 2013. The stock option vests immediately as to 21,250 shares and vests as at a rate of 5,313 shares on each three (3) month anniversary of the Grant Date.